Clovis Oncology Inc (NASDAQ:CLVS)

Delayed Data
As of May 20
 +0.0066 / +0.93%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +386.18% increase from the last price of 0.72.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.06%
Growthannually 27.37%


Growthquarterly 13.38%
Growthannually 5.01%
Key to the earnings and sales forecast charts.